Pure Global

Syphilis Ab Rapid Test - India CDSCO Medical Device Registration

Syphilis Ab Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000139_599b32e873699a913259abc373b9d3fd_fb9ea1776e4351aa1e5b1a9ddd742039. The license holder is LABGENE BIO-TECH PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Syphilis Ab Rapid Test
UID: MFG/IVD/2022/000139_599b32e873699a913259abc373b9d3fd_fb9ea1776e4351aa1e5b1a9ddd742039

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

The Syphilis Ab Rapid test kit is a rapid immunochromatography assay for the qualitative detection of antibodies against Treponema pallidum in human whole blood, serum or plasma samples

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing